According to BioNexus Gene Lab's latest financial reports and stock price the company's current Operating Margin is -9.93%. At the end of 2022 the company had an Operating Margin of -2.66%.
Year | Operating Margin | Change |
---|---|---|
2022 | -2.66% | -133.72% |
2021 | 7.90% | -29.35% |
2020 | 11.18% | -105.15% |
2019 | -217.17% | -869.78% |
2018 | 28.21% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.